Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.celrep.2021.109292
DC FieldValue
dc.titleRecurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
dc.contributor.authorMeng, Bo
dc.contributor.authorKemp, Steven A.
dc.contributor.authorPapa, Guido
dc.contributor.authoret al.
dc.date.accessioned2022-10-11T07:56:50Z
dc.date.available2022-10-11T07:56:50Z
dc.date.issued2021-06-01
dc.identifier.citationMeng, Bo, Kemp, Steven A., Papa, Guido, et al. (2021-06-01). Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7. Cell Reports 35 (13) : 109292. ScholarBank@NUS Repository. https://doi.org/10.1016/j.celrep.2021.109292
dc.identifier.issn2211-1247
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/232063
dc.description.abstractWe report severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike ΔH69/V70 in multiple independent lineages, often occurring after acquisition of receptor binding motif replacements such as N439K and Y453F, known to increase binding affinity to the ACE2 receptor and confer antibody escape. In vitro, we show that, although ΔH69/V70 itself is not an antibody evasion mechanism, it increases infectivity associated with enhanced incorporation of cleaved spike into virions. ΔH69/V70 is able to partially rescue infectivity of spike proteins that have acquired N439K and Y453F escape mutations by increased spike incorporation. In addition, replacement of the H69 and V70 residues in the Alpha variant B.1.1.7 spike (where ΔH69/V70 occurs naturally) impairs spike incorporation and entry efficiency of the B.1.1.7 spike pseudotyped virus. Alpha variant B.1.1.7 spike mediates faster kinetics of cell-cell fusion than wild-type Wuhan-1 D614G, dependent on ΔH69/V70. Therefore, as ΔH69/V70 compensates for immune escape mutations that impair infectivity, continued surveillance for deletions with functional effects is warranted. © 2021 The Author(s)
dc.publisherElsevier B.V.
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceScopus OA2021
dc.subjectAlpha variant
dc.subjectantibody escape
dc.subjectB.1.1.7
dc.subjectCOVID-19
dc.subjectdeletion
dc.subjectinfectivity
dc.subjectneutralizing antibodies
dc.subjectresistance
dc.subjectSARS-CoV-2
dc.subjectspike mutation
dc.typeArticle
dc.contributor.departmentMICROBIOLOGY AND IMMUNOLOGY
dc.contributor.departmentMEDICINE
dc.description.doi10.1016/j.celrep.2021.109292
dc.description.sourcetitleCell Reports
dc.description.volume35
dc.description.issue13
dc.description.page109292
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1016_j_celrep_2021_109292.pdf5.82 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons